{
    "code": 0,
    "data": [
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please see enclosed disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22c039ab-d221-45e6-8cc6-ec6a50b0c157.pdf",
            "news_date": "2026-02-11 18:39:10"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release- Collaboration of Piramal Critical Care Inc (PCCI) and Blue-Zone Technologies Ltd (Blue-Zone) to capture collect and recycle waste anaesthetic gases",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc0a4c0f-9f42-421d-a70e-072740be1d01.pdf",
            "news_date": "2026-02-05 23:16:16"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please see intimation of completion of term of Independent Director Mr. Subramanian Ramadorai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=333758ba-151e-41ca-9de5-0e5911adff02.pdf",
            "news_date": "2026-02-05 10:31:37"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please refer attached file",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9550ce25-777c-4bf4-a3e2-0d15218af7bf.pdf",
            "news_date": "2026-02-04 22:07:06"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended December 31 2025",
            "news_id": "b29ca260-fad2-4229-ba2c-17965f19a8a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1052a148-c60c-4716-ae9c-4a49d73d516a.pdf",
            "news_date": "2026-01-30 17:57:51",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1052a148-c60c-4716-ae9c-4a49d73d516a.pdf",
            "news_date": "2026-01-30 17:57:51"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December 2025",
            "news_id": "3308aed4-3b30-42d5-a19c-c7cf0e92af43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e571e6-b421-4ea7-b782-bc5d3aaa33b7.pdf",
            "news_date": "2026-01-29 16:52:45",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e571e6-b421-4ea7-b782-bc5d3aaa33b7.pdf",
            "news_date": "2026-01-29 16:52:45"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Please refer attached file",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b28a9de9-1aa2-40f2-887a-8b8a03fa8fdd.pdf",
            "news_date": "2026-01-29 00:18:07"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Please refer attached file",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=843bcc3f-a72e-4e78-a553-8b297fc9dad0.pdf",
            "news_date": "2026-01-29 00:16:39"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed Investor Presentation",
            "news_id": "4618ad3c-582a-4c65-9488-324767d1593b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94be2676-fca1-4eeb-9e5c-fa84c33674c3.pdf",
            "news_date": "2026-01-29 00:13:11",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94be2676-fca1-4eeb-9e5c-fa84c33674c3.pdf",
            "news_date": "2026-01-29 00:13:11"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please see enclosed Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00c6eb45-3d4f-4c58-86e9-69ee9f3ecd2b.pdf",
            "news_date": "2026-01-29 00:11:32"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended December 31 2025",
            "news_id": "d8fc4190-12dd-418b-a165-f7268a90c074",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2871069a-9572-48d6-8443-199dd3b96fe8.pdf",
            "news_date": "2026-01-29 00:00:51",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2871069a-9572-48d6-8443-199dd3b96fe8.pdf",
            "news_date": "2026-01-29 00:00:51"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please refer attached file",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec28cbac-d5a9-44a2-a46d-d91079af89c8.pdf",
            "news_date": "2026-01-28 23:58:50"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR)- Acquisition Of Kenalog\u00ae A Branded Commercial Injectable Product",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=854dbadb-2a8b-4f89-a703-1d9d07a13626.pdf",
            "news_date": "2026-01-28 23:57:22"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated January 28 2026",
            "news_body": "Please find enclosed outcome of Board Meeting held on January 28 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd285e0c-f6c7-4b38-af17-bf9df92c06a4.pdf",
            "news_date": "2026-01-28 23:54:43"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46f518b7-d8e4-414b-bbab-f3c3c9222076.pdf",
            "news_date": "2026-01-21 16:40:21"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Please see enclosed disclosure of E-voting Results and Scrutinizers Report on the Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac01a20e-d11b-401f-ac77-cbceffd50721.pdf",
            "news_date": "2026-01-16 21:45:31"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) of the SEBI Listing Regulations please find enclosed herewith the details of the Conference Call with investors/ analysts.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72139ed0-c87d-4071-b690-d2aa3f476fb6.pdf",
            "news_date": "2026-01-16 12:21:56"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months Ended 31St December 2025.",
            "news_body": "Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17493227-8013-41b6-812c-5002b1edf09a.pdf",
            "news_date": "2026-01-16 12:18:10"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of copy of newspaper advertisement for Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caf20ef2-abe3-40ef-a8da-4e80ebad4fae.pdf",
            "news_date": "2025-12-18 14:36:09"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find enclosed Postal Ballot Notice intimation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c8cb2a7-1dc6-493d-ab0c-426bcd759fe6.pdf",
            "news_date": "2025-12-17 15:11:22"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find enclosed Postal Ballot Notice intimation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25c302c9-20e0-4659-b1a4-ed785b5054f3.pdf",
            "news_date": "2025-12-17 14:45:01"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA Inspection",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- FDA Inspection",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68cc8f85-c6a6-4722-870d-b6b22dcf7f00.pdf",
            "news_date": "2025-12-11 20:01:34"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Please find enclosed intimation of appointment of Independent Director.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a33af86-77e2-465a-a18f-16a3e698c3ef.pdf",
            "news_date": "2025-12-08 18:12:14"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04b02560-8b37-4e11-9b0f-577e5f88c34f.pdf",
            "news_date": "2025-11-19 16:48:12"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30 2025",
            "news_id": "c7e79751-3424-45c1-b2eb-6a05e3016c56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=613b1fb0-5d63-4527-8fb7-e67860d13044.pdf",
            "news_date": "2025-11-07 15:13:23",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=613b1fb0-5d63-4527-8fb7-e67860d13044.pdf",
            "news_date": "2025-11-07 15:13:23"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September 2025",
            "news_id": "6018e24e-a149-42f7-95ff-26a8560e7b6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c3932c1-b587-4e35-9cd2-58ea4e3b0f0e.pdf",
            "news_date": "2025-11-06 12:26:21",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c3932c1-b587-4e35-9cd2-58ea4e3b0f0e.pdf",
            "news_date": "2025-11-06 12:26:21"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please see enclosed Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30 2025",
            "news_id": "89b86a6e-9c00-47d9-af4c-f2f3eeb2471e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f67db704-3ad8-48fe-baeb-efaaa2dc2d88.pdf",
            "news_date": "2025-11-05 21:05:01",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please see enclosed Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f67db704-3ad8-48fe-baeb-efaaa2dc2d88.pdf",
            "news_date": "2025-11-05 21:05:01"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please see enclosed Press Release - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72621249-90bb-4539-b40e-096ac18a6337.pdf",
            "news_date": "2025-11-05 21:02:35"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For Quarter Ended September 30 2025",
            "news_body": "Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended September 30 2025",
            "news_id": "ca91db47-f232-440c-a9b7-44d69a50713d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32a65634-dd99-4062-b6d8-2c2f6dd69041.pdf",
            "news_date": "2025-11-05 21:00:03",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results - Financial Results For Quarter Ended September 30 2025",
            "news_body": "Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32a65634-dd99-4062-b6d8-2c2f6dd69041.pdf",
            "news_date": "2025-11-05 21:00:03"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated November 5 2025",
            "news_body": "Please find enclosed outcome of Board Meeting held on November 5 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61f84b58-6ca6-4086-ad0f-1a30ca7dffa2.pdf",
            "news_date": "2025-11-05 20:55:23"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6df052fe-4bbe-4a1b-a6a3-c60c043936f0.pdf",
            "news_date": "2025-11-03 17:25:27"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) of the SEBI Listing Regulations please find enclosed herewith the details of the Conference Call with investors/ analysts.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b013aac-f457-46df-874b-06fdd94fb3fe.pdf",
            "news_date": "2025-10-24 12:13:15"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Half Year Ended 30Th September 2025.",
            "news_body": "Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59c248ed-2f78-4c53-8e84-68ee5cbcc337.pdf",
            "news_date": "2025-10-24 12:08:09"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Withdrawal of Credit Rating.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3d594c3-6ac5-426c-b67f-49cdcb39ab15.pdf",
            "news_date": "2025-10-16 20:41:00"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General - Update",
            "news_body": "Please find enclosed intimation on change in general email id of Companys Registrar & Share Transfer Agent.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6f01f18-7f52-4d9c-a579-c46bdf08125d.pdf",
            "news_date": "2025-09-30 18:24:56"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Code of Conduct under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
            "news_body": "Amendment to the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d02606e-f009-4966-8d3a-9ed69576dea4.pdf",
            "news_date": "2025-09-09 18:52:52"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fbcd282-4ac8-43a0-9929-dee0ac269251.pdf",
            "news_date": "2025-09-02 15:44:41"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Sustainability Report - FY2024-25",
            "news_body": "Sustainability Report of Piramal Pharma Limited for the Financial Year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70375a0f-d917-4532-a822-84393c0c5250.pdf",
            "news_date": "2025-08-25 16:15:59"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release- Piramal Pharma Solutions (\"PPS\") and NewAmsterdam Pharma invest in dedicated suite to enhance Oral Solid Dosage capabilities at PPS Sellersville  Pennsylvania site",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e450d840-bf91-4423-bda6-68392da20254.pdf",
            "news_date": "2025-08-21 16:55:35"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=193af599-819b-43b9-932a-8be66dbc658f.pdf",
            "news_date": "2025-08-20 21:07:11"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45209902-5dc5-4895-b7df-30e224bf2fcd.pdf",
            "news_date": "2025-08-20 18:03:32"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Fire  occurrence at a third-party warehouse utilized by Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da27fe7e-0845-469c-ba98-6e5ca2735a33.pdf",
            "news_date": "2025-08-07 18:49:34"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor  Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d40be64f-88cd-4002-9c31-9c6e461e29bf.pdf",
            "news_date": "2025-08-04 15:19:14"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c75de9c-530d-4d26-a685-d803fd0d1176.pdf",
            "news_date": "2025-07-31 14:04:52"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Proceedings and Voting Results of the 5th AGM of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0051818a-7086-4dd8-9761-97160588f705.pdf",
            "news_date": "2025-07-30 21:19:51"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings and Voting Results of the 5th AGM of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8becf4ea-6515-4184-8210-c3487c40e266.pdf",
            "news_date": "2025-07-30 21:16:49"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025",
            "news_id": "d4592a45-f7e6-43eb-8f69-aab33a840ef6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85945f2b-9feb-4628-bfd6-5969edbc57d9.pdf",
            "news_date": "2025-07-29 12:28:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85945f2b-9feb-4628-bfd6-5969edbc57d9.pdf",
            "news_date": "2025-07-29 12:28:58"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Please refer attachment",
            "news_id": "4944adbf-9431-4937-a9d1-11eb928e9f4b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f13fadb0-a355-4091-803d-ca4c581b32f6.pdf",
            "news_date": "2025-07-28 21:59:39",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f13fadb0-a355-4091-803d-ca4c581b32f6.pdf",
            "news_date": "2025-07-28 21:59:39"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025",
            "news_id": "03e45441-4e57-4147-abe9-1ba223c26b31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03caf78a-1ca0-4ca9-9e2c-4f8eec46ead1.pdf",
            "news_date": "2025-07-28 21:49:37",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03caf78a-1ca0-4ca9-9e2c-4f8eec46ead1.pdf",
            "news_date": "2025-07-28 21:49:37"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release and Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af25dd79-431c-43a1-99f3-9a6581e97515.pdf",
            "news_date": "2025-07-28 21:46:32"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Of Piramal Pharma Limited Held On 28Th July 2025",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e411a56-e505-4f55-bc3f-01995cabec91.pdf",
            "news_date": "2025-07-28 21:33:09"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Grant Of Stock Options",
            "news_body": "Grant of Stock Options pursuant to Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2e70021-11d0-4c67-a8c3-d1b29967f8f4.pdf",
            "news_date": "2025-07-28 17:30:28"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Restructuring",
            "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Update on Sale of decommissioned unit",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33e4e4f5-fbe3-455a-a606-fc64173a3027.pdf",
            "news_date": "2025-07-22 10:01:25"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3e8f945-a685-424e-b581-c7daafb12f66.pdf",
            "news_date": "2025-07-21 12:33:07"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Conference Call with Investors/Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e10b63cf-50a5-46f8-82ce-77afc63237fb.pdf",
            "news_date": "2025-07-18 14:16:52"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)",
            "news_body": "Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e697c1e-b9d5-4d42-92be-1ff1dc169575.pdf",
            "news_date": "2025-07-18 14:05:59"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - ESG Rating",
            "news_body": "Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 - ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffb0e246-3afc-4f62-96f2-f6c88fbbeb74.pdf",
            "news_date": "2025-07-10 11:17:51"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Company Update On Litigation",
            "news_body": "Company Update on Litigation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae258fba-ece3-402d-bc04-3afe919d8b15.pdf",
            "news_date": "2025-07-04 17:16:41"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement titled Notice of the 5th Annual General Meeting and E-voting information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de4e12c7-4ebf-458a-9e37-9b2051ae9cf5.pdf",
            "news_date": "2025-07-03 16:01:40"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility & Sustainability Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ace4812-72e7-4184-b077-bd2db1f4096b.pdf",
            "news_date": "2025-07-02 13:02:52"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of The 5Th Annual General Meeting (AGM) And Annual Report For The Financial Year 2024-25",
            "news_body": "Notice of the 5th Annual General Meeting (AGM) and Annual Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c05df55f-557e-40de-81e1-73cdf19b61de.pdf",
            "news_date": "2025-07-02 12:59:55"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Notice of the 5th Annual General Meeting (AGM) and Annual Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33c9f38c-0692-4e04-b789-77605f82aa29.pdf",
            "news_date": "2025-07-02 12:52:53"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C301B26A_21FE_4BEA_901F_2C8C37A99B93_173344.pdf",
            "news_date": "2025-06-27 17:33:48"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Newspaper Advertisement regarding 5th Annual General Meeting (AGM) and Record Date for final dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd0402e0-919a-47f1-bc98-c80f22cd9371.pdf",
            "news_date": "2025-06-26 19:13:16"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Dividend/AGM",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "Intimation of Record Date for payment of Final Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47ebe731-2570-403b-b207-040838328eaa.pdf",
            "news_date": "2025-06-13 18:04:10"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For Payment Of Final Dividend",
            "news_body": "Intimation of Record Date for payment of Final Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec9dfe01-c230-4708-a042-b0248998e153.pdf",
            "news_date": "2025-06-13 18:01:33"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of 5Th Annual General Meeting To Be Held On Wednesday July 30 2025",
            "news_body": "Intimation of Annual General Meeting to be held on Wednesday July 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c472115-6364-48e3-af4f-efd9c22361d3.pdf",
            "news_date": "2025-06-13 17:57:21"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations)",
            "news_body": "Appointment of N L Bhatia & Associates Practicing Company Secretaries as Secretarial Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bee7b53f-bcb3-4a9d-87ab-a2b3d3d105af.pdf",
            "news_date": "2025-06-13 17:52:53"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Statutory Auditor/s",
            "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended (SEBI Listing Regulations)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea601587-58e5-40fe-817f-b3c69b836c2c.pdf",
            "news_date": "2025-06-13 17:48:09"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df4416bd-db3d-498d-8d37-18e2d83bd324.pdf",
            "news_date": "2025-06-02 12:28:20"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - US FDA Inspection at Aurora facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54c3f0ac-a284-41b7-9d6f-06eca3073e7e.pdf",
            "news_date": "2025-06-02 10:22:51"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc3817b1-7fcf-41ff-bbd6-70aef8f7d14f.pdf",
            "news_date": "2025-05-26 16:17:05"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7679b070-cb44-4694-82de-fca0dfb16d11.pdf",
            "news_date": "2025-05-21 15:27:40"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35980f5e-75ea-4aa7-ae60-d76229b3c643.pdf",
            "news_date": "2025-05-16 16:43:57"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2025",
            "news_id": "b8da426a-0a09-4552-adb6-b2cbbd5638b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b428052b-efdb-4cb2-88e1-30e908216418.pdf",
            "news_date": "2025-05-15 14:57:33",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b428052b-efdb-4cb2-88e1-30e908216418.pdf",
            "news_date": "2025-05-15 14:57:33"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Dividend Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=260828cc-0227-4967-9b17-77cb953e059e.pdf",
            "news_date": "2025-05-14 20:58:43"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed45793b-c73f-4c8f-aa5c-090a8117f227.pdf",
            "news_date": "2025-05-14 20:57:18"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=907d76a4-3db6-4eda-a687-fab97948a79c.pdf",
            "news_date": "2025-05-14 20:56:07"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment",
            "news_id": "5eee7f4c-3edc-4100-a998-a9a19f5e4394",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba18641e-a77f-4d2d-ad62-b50bc644d450.pdf",
            "news_date": "2025-05-14 20:54:18",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba18641e-a77f-4d2d-ad62-b50bc644d450.pdf",
            "news_date": "2025-05-14 20:54:18"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2025",
            "news_body": "Please refer attachment",
            "news_id": "5b8ebd91-4980-4467-a0b2-96815f0cbc92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd0d01f2-e1cb-472b-9d81-b420114031a0.pdf",
            "news_date": "2025-05-14 20:52:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2025",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd0d01f2-e1cb-472b-9d81-b420114031a0.pdf",
            "news_date": "2025-05-14 20:52:22"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Of Piramal Pharma Limited (Company) Held On 14Th\r\nMay 2025",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7148ca29-4792-4cbc-a1bb-d4debacacc82.pdf",
            "news_date": "2025-05-14 20:46:04"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations) - Capacity Expansion Of Lexington And Riverview Sites",
            "news_body": "Capacity Expansion of Lexington and Rivervew Sites",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef94c091-c0aa-421d-ab5f-86a08e5fb5af.pdf",
            "news_date": "2025-05-12 16:59:45"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) -Successful Closure Of US FDA Inspection At Piramal PharmaS Manufacturing Facility Located At Turbhe",
            "news_body": "Sucessful closure of US FDA Inspection at Piramal Pharmas Manufacturing Facility located at Turbhe.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c4916a1-14f4-437c-8a98-b0ffdc287777.pdf",
            "news_date": "2025-05-12 10:59:44"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a325eae-586e-457b-973f-33d049e93172.pdf",
            "news_date": "2025-05-05 18:21:41"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Conference Call with Investor/Analysts under the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=995fa8ea-4798-4213-b699-a0c66ab1e2a8.pdf",
            "news_date": "2025-04-29 17:07:15"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2025 and to consider recommending payment of dividend to the shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=157d16ce-1003-4bcd-ab6f-2dfb4a372a79.pdf",
            "news_date": "2025-04-29 17:00:18"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64ca63cc-0ff1-4b39-86e1-ef8e83fd1c7d.pdf",
            "news_date": "2025-04-23 21:42:41"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)",
            "news_body": "Disclosure under Regulation 30 of the securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) regulations 2015 (\"SEBI Listing Regaultions\")",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d145b1b4-4e32-4e83-97e9-ea57461301ab.pdf",
            "news_date": "2025-04-01 22:30:01"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "E-voting Results and Scrutinizers Report on Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdc5895c-f34a-4941-b062-800817014782.pdf",
            "news_date": "2025-03-21 19:45:56"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Piramal Critical Care and BrePco announces MHRA approval for Neoatricon in the UK.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e4d15e3-b18d-4b75-bd43-cb3319efac28.pdf",
            "news_date": "2025-03-20 17:06:54"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56941b46-2652-46e8-9c15-4484564c79cb.pdf",
            "news_date": "2025-03-11 17:20:00"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of copy of newspaper advertsiment for Postal Ballot Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22d89e88-d50b-42b6-87d1-cbb10ede1993.pdf",
            "news_date": "2025-02-20 14:52:59"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Submission of Postal Ballot Notice & Intimation of Remote E-Voting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56885e68-6ee2-40ec-b754-6f9797a347e5.pdf",
            "news_date": "2025-02-19 17:08:18"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) -US FDA Inspection At Piramal PharmaS Facility Located At Turbh",
            "news_body": "Intimation under Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015 (\"SEBI Listing Regualtions\") - US FDA Inspection at Piramal Pharmas facility located at Turbhe.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b594ffc5-262e-4ea4-804f-1b57af3246cd.pdf",
            "news_date": "2025-02-18 17:00:36"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Change In Domain Name And Generic E-Mail ID Of The Registrar And Share Transfer Agent (RTA) Of Company",
            "news_body": "Intimation for change in Domain name and Generic e-mail ID of  Registrar and Share Transfer Agent (RTA) of the company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fef52cc-498e-4062-aae8-3706e6493e2e.pdf",
            "news_date": "2025-02-18 16:40:06"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e847564d-2d2a-40ad-baa9-2a5d298e8a35.pdf",
            "news_date": "2025-02-17 17:53:56"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Extension Of Timeline Communicated For Sale Of CompanyS Unit Situated At Thane",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Extension of timeline communicated for sale of Companys Unit situated at Thane.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8acb55eb-d290-4df2-84a0-0141b6c63202.pdf",
            "news_date": "2025-01-31 10:31:04"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024",
            "news_id": "6124c83a-e147-4c69-9272-b89a0182a1f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0198dac-d4ee-42f4-bef0-7ce2fa830d79.pdf",
            "news_date": "2025-01-30 20:25:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0198dac-d4ee-42f4-bef0-7ce2fa830d79.pdf",
            "news_date": "2025-01-30 20:25:58"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=789f076c-6fc5-4b5f-a43b-5b54b8aa0cde.pdf",
            "news_date": "2025-01-30 20:13:14"
        },
        {
            "co_code": 76066,
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e5cf4d1-3338-4d63-b3dd-2268257ed155.pdf",
            "news_date": "2025-01-29 19:22:05"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for UFR - 31st December 2024",
            "news_id": "b0d40c06-6a5f-4ddb-989c-dea559fc5cee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee092d7d-2fb3-45e0-8cfd-1cc325533a34.pdf",
            "news_date": "2025-01-28 20:56:38",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Please refer attachment.",
            "news_id": "6141e5be-d310-46d9-95ae-f9f1a647c2f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76dfe36d-67ad-467c-a249-f49765c60fd7.pdf",
            "news_date": "2025-01-28 20:46:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please refer attachment.",
            "news_id": "428b5feb-c857-4076-8971-bd20279afdbc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b45bd32-998e-4451-bf41-a95b0028c16a.pdf",
            "news_date": "2024-10-26 13:43:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment.",
            "news_id": "38fd8b01-af1b-4f4c-9fc4-3601ae88a9f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b745cfe-e39e-485e-9aad-b2d8615981f3.pdf",
            "news_date": "2024-10-23 20:16:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2024",
            "news_body": "Please refer attachment.",
            "news_id": "1b2972f6-2879-454b-aecf-494583b94a3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd57c8cf-1d4a-4ed3-8967-4182ba3cbaac.pdf",
            "news_date": "2024-10-23 20:07:58",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment.",
            "news_id": "444d1c93-abfe-47aa-a209-3caba813d963",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3419ae7-735b-499c-8840-4308d9b6a8a3.pdf",
            "news_date": "2024-09-24 17:06:04",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As per attachment.",
            "news_id": "6675a0e3-55da-4e8a-9dbf-8da8d83533c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c1a28b-7865-404f-b326-1cd57ff20984.pdf",
            "news_date": "2024-07-29 17:20:40",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment.",
            "news_id": "13cb4b6f-058d-4214-a9fa-4b646d79b3ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773bd656-ff69-4552-9022-1a324a36e796.pdf",
            "news_date": "2024-07-26 12:52:20",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June 2024",
            "news_body": "As per attachment.",
            "news_id": "cc5ed32c-d595-4d68-b694-a2a386dbe385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f697efe5-4196-4896-8241-84e6f3936ce6.pdf",
            "news_date": "2024-07-26 12:41:26",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2024",
            "news_id": "2e9f66a8-3d20-4b96-80fa-ff07a060ec8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81638c1-2532-47c6-804e-2cfffcb28dc8.pdf",
            "news_date": "2024-05-14 19:14:11",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2024",
            "news_id": "e4d95cca-75d2-4e89-829c-03ffeffd33c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41fd3fe8-e3f8-4456-af9e-19ea97fc6dc9.pdf",
            "news_date": "2024-05-13 20:11:53",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attachment.",
            "news_id": "0a2873bc-ade6-46f8-aeb0-9535f94d40ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31adf91-163b-483e-8bc5-d031150ad183.pdf",
            "news_date": "2024-05-10 20:48:22",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended 31St March, 2024",
            "news_body": "Please refer attachment.",
            "news_id": "d2b39fe1-d974-4a02-8b6f-e7eab84b5944",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3564c28a-e817-49ca-b6ce-4f3868f0fc76.pdf",
            "news_date": "2024-05-10 20:31:35",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2023.",
            "news_id": "31cc2155-8c18-496c-aa77-e3b78c6a4bc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eae6a10-35a1-46aa-a7ef-05be49089434.pdf",
            "news_date": "2024-02-02 11:38:00",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2023",
            "news_id": "a2a9d321-13cf-4d72-aed5-5a435b291374",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=988929ae-4f86-4464-9f02-531ce8dfc696.pdf",
            "news_date": "2024-01-31 20:33:39",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presentation of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2023.",
            "news_id": "ce3d0aa2-9b55-4380-939c-6b4e0e7c2655",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09998dde-6fa7-4362-a05f-36cb577314b1.pdf",
            "news_date": "2024-01-30 21:06:02",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended 31St December, 2023",
            "news_body": "Unaudited Financial results (standalone & consolidated) for the quarter and nine months ended 31st December 2023",
            "news_id": "22444504-a002-4f3f-98aa-e775fc937fe3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56bf9248-8650-4af5-bb8e-6cbe7d24000e.pdf",
            "news_date": "2024-01-30 20:52:28",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023.",
            "news_id": "1247fae3-bfa9-4ec6-9c30-b69c09e9b815",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bbea31c-3c22-4448-b5fe-2f81c4ab1e5c.pdf",
            "news_date": "2023-10-31 20:42:35",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023",
            "news_id": "3fa37054-d175-48a7-bed5-a5e5dbf553a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0df15461-4929-4b6c-9f31-b2425ec7e285.pdf",
            "news_date": "2023-10-30 16:18:21",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presentation",
            "news_id": "4929afb0-3240-4050-94ac-5d8786897503",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eff008fb-5727-4869-a935-3b25ff3d280e.pdf",
            "news_date": "2023-10-27 22:26:27",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited (The 'Company') Held On 27Th October, 2023",
            "news_body": "Board Meeting Outcome - Results",
            "news_id": "7f2be1a1-d94b-4dd1-a34f-500a0a70231a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7e6b2b4-9d6c-471b-973c-2c317d8af42d.pdf",
            "news_date": "2023-10-27 22:15:37",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited (The 'Company') Held On 27Th October, 2023",
            "news_body": "Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited (the 'Company') held on 27th October, 2023",
            "news_id": "125cd216-cc3e-438e-87d7-37b63d103dc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5baea71f-a29e-4048-979c-1f37a95880d1.pdf",
            "news_date": "2023-10-27 22:13:04",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Investors/Analysts",
            "news_id": "e09df536-0d90-48b2-ab58-721261750e35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ba1620-cbf0-4c99-8932-6d5fb601bb41.pdf",
            "news_date": "2023-08-07 20:26:02",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Investors/Analysts",
            "news_id": "46b32326-3229-4491-b94a-bb001e78c2a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49ee2aae-4c46-4f28-bc85-6d1a36850150.pdf",
            "news_date": "2023-08-07 20:19:11",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter ended 30th June, 2023",
            "news_id": "e418e4f2-ac36-40c6-92ac-7a0b4f79860b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be81733e-d7c1-4ca4-97c3-d580499dca23.pdf",
            "news_date": "2023-08-04 15:05:37",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presenation - Unaudited Financial Results(Standalone and Consolidated) of the company for quarter ended 30th June, 2023",
            "news_id": "5ae2e681-8122-4e2e-a0cf-3369a43b31fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a68b299-2d4e-49b0-91be-23c34fa3d132.pdf",
            "news_date": "2023-08-03 21:11:28",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited Held On 3Rd August, 2023",
            "news_body": "Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited held on 3rd August, 2023",
            "news_id": "7b33e674-ed12-4f1b-87cf-62eae24dfcd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a46c570f-25d6-473b-b863-b73cd916b160.pdf",
            "news_date": "2023-08-03 21:10:09",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited Held On 3Rd August, 2023",
            "news_body": "Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited held on 3rd August, 2023",
            "news_id": "254744a4-cb3d-4a38-846e-352491931ac7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b9aa5f3-5635-4142-9d0d-409fddc81a0b.pdf",
            "news_date": "2023-08-03 21:06:06",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Transcript of Conference Call with Investors/Analysts",
            "news_id": "cb143b82-87b0-4199-92d9-299746b89a12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2afe7cf7-1cfe-4723-a414-5d13de8b76d1.pdf",
            "news_date": "2023-05-29 14:52:26",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call On The Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March, 2023",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023",
            "news_id": "0b93dd4e-9f01-4b7f-8641-33804bdcfc6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e80073f-6301-4d83-8da9-20b4e4aeba84.pdf",
            "news_date": "2023-05-25 20:27:10",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Press Release and Investor Presentation - Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended 31st March, 2023",
            "news_id": "e22789cd-e615-40f3-a4b3-ad917c0a72f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15f5da78-aed7-4b3a-a11f-f18f57b84b80.pdf",
            "news_date": "2023-05-24 22:00:07",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March, 2023",
            "news_body": "Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2023",
            "news_id": "43888123-2dde-46ff-868c-7d8d86efbcc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8e4c938-c31d-4a49-90c1-235950f68c11.pdf",
            "news_date": "2023-05-24 21:49:49",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Conference Call with Investors/Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 ('Listing Regulations')",
            "news_id": "b63faf13-8bee-48bf-9172-9d7eafdec8d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaa99ab0-6535-4fa4-967a-e05e80f05c3e.pdf",
            "news_date": "2023-05-18 09:48:13",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call with Investors/Analysts",
            "news_id": "5a0c787c-9853-49c6-8829-40808ab26d52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f89fd316-2534-49c7-8e0a-f88dcc77a178.pdf",
            "news_date": "2023-02-13 11:57:00",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022",
            "news_id": "0195781b-c273-4ac4-98a0-9cf5ba2b158c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3317664b-3590-4ae7-a4c6-237bead4bad5.pdf",
            "news_date": "2023-02-09 19:37:09",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Meeting Of The Board Of Directors Of Piramal Pharma Limited (The 'Company') Held On 8Th February, 2023",
            "news_body": "We wish to inform you that, the board of directors of the Company ('Board'), at its meeting held today, 8th February, 2023, has inter alia considered and approved the following:",
            "news_id": "9ee4613a-8fa9-4f38-a60d-80b06f5f4413",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eb5ae63-8424-47b4-ab22-0a6b2e6f9226.pdf",
            "news_date": "2023-02-08 21:12:03",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')",
            "news_id": "280456e3-e6c1-47ca-b89c-0904729bbf7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab423a6d-29d6-4931-a48e-39f9293fb929.pdf",
            "news_date": "2023-01-05 17:43:42",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed herewith disclosure of related party transactions for the half year ended 30th September, 2022.",
            "news_id": "21159fc1-670b-46b1-bab0-71d06b2b6df8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5645fad5-1b1e-47f6-b310-5f6341472298.pdf",
            "news_date": "2022-11-22 21:49:03",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Transcript of Conference Call with Investors/Analysts",
            "news_id": "d936bf59-7944-4a79-bb82-01925585dd58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2a967d4-a3e8-4799-9372-08075b413bfc.pdf",
            "news_date": "2022-11-11 13:03:17",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call on the financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2022",
            "news_id": "c2bbbd82-559b-4d19-b36b-66117c3d629d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3b34206-4c49-4c71-a2cb-b00ce319689b.pdf",
            "news_date": "2022-11-09 20:25:45",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "In compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company at its meeting held today, i.e. 08th November, 2022, has inter alia, approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2022.",
            "news_id": "d0ede05b-e7a0-4b31-878f-b10b4b0111cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6a0ecca-0b6a-4b89-809c-2105acf2f971.pdf",
            "news_date": "2022-11-08 21:31:12",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "PPLPHARMA",
            "disp": "Piramal Pharma",
            "bse_code": 543635,
            "isin": "INE0DK501011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "In compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company at its meeting held today, i.e. 08th November, 2022, has inter alia, approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2022.",
            "news_id": "e4abc181-19c3-4792-b6ef-6ad13a3b091e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a6325de-fddf-4780-982c-58a4893c18eb.pdf",
            "news_date": "2022-11-08 21:22:40",
            "seo": "piramal-pharma-ltd",
            "ltp": 164.36,
            "ch": 0.9400000000000261,
            "pch": 0.5752049932688937,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11571,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}